Key Note 1 – The State of the Art in Cardiomyopathy

8 Views

Thanks! Share it with your friends!

You disliked this video. Thanks for the feedback!

Published Feb 3, 2025

Professor Perry Elliott, President of Cardiomyopathy UK, is invited to deliver the first Key Note presentation at the Cardiomyopathy UK National Conference 2024.
Help us be there for everyone that needs us through a one-off donation or a regular gift – https://www.cardiomyopathy.org/donate
Chapters:
00:02:30 – The ESC Guidelines for the management of cardiomyopathies
00:02:56 – Treatment in cardiomyopathy
00:04:34 – Why do we need a new approach?
00:06:55 – How good are we at treating symptoms?
00:08:34 – Myosin inhibitors
00:11:56 – Targeting the cause as well as the consequences of the disease
00:14:02 – Nucleic Acid Therapies
00:15:17 – New trial designs?

Perry Elliott is Professor of Cardiovascular Medicine at University College London and a Senior Investigator of the UK National Institute for Health Research. He is director of the UCL Institute of Cardiovascular Science and a consultant cardiologist at St. Bartholomew's Hospital London. He is Chairman of the European Society of Cardiology (ESC) Heart Academy and past chair of the ESC Council on Cardiovascular Genomics, the ESC Working Group on Myocardial and Pericardial Diseases and the Executive Committee for the European Outcomes Research Programme registry on cardiomyopathies. He is an executive Editor for the European Heart Journal. Perry Elliott is a recognised world authority in heart muscle disease. His most important research contributions include: gene identification; development and application of risk tools; biomarker discovery, and clinical trials in rare diseases.

Visit www.cardiomyopathy.org for more information